ADmark® ApoE Genotype Analysis and Interpretation (Symptomatic)
Also known as: Apolipoprotein 3 Genotyping, ApoE Genotype
Use
ADmark® ApoE Genotype Analysis and Interpretation (Symptomatic) is intended for symptomatic patients to detect APOE alleles (E2, E3, E4), which are genetic risk factors for dementia and Alzheimer’s disease. It is specifically indicated only for individuals presenting dementia symptoms and not for asymptomatic individuals; genetic counseling is strongly recommended pre- and post-test.
Special Instructions
Not provided.
Limitations
Not provided.
New York Approved
Methodology
PCR-based
Biomarkers
APOE
Gene
LOINC Codes
- 42315-2 - APOE allele e2+e3+e4 Bld/T
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
8 mL
Minimum Volume
6 mL
Container
EDTA (lavender-top) tube
Collection Instructions
Sample must be noted as “symptomatic” and patient must be 18 years or older.
Causes for Rejection
Samples not noted as “symptomatic” and samples for patients under 18 years of age will be rejected.
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | DNA yields and quality are better in fresh specimens. |
Other tests from different labs that may be relevant